Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
SER-155, an investigational oral 16-strain cultivated microbiome therapeutic developed by Seres Therapeutics, aims to reduce complications in patients undergoing allogeneic hematopoietic stem cell transplants (allo-HSCT), including acute graft-versus-host disease (aGVHD). That means, reducing bloodstream infections post-transplant and potentially improving other allo-HSCT complications related to microbiome disruption.
NCT04995653
SER-155 was generally well-tolerated through Day 100, with no…